Exhibitors
Become An Exhibitor
You are cordially invited to become an exhibitor at the 22nd Annual World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease (WCIRDC).
We offer Exhibit space to expand your company’s appreciation, and to expose your products, and services to nearly 600 healthcare professionals who attend the annual meeting, online.
WCIRDC is committed to giving exhibitors the best value for their participation.
The 22nd Annual WCIRDC is an excellent opportunity to meet with globally recognized medical leaders, clinicians, and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.
The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state-of-the-art approach: “Exploring New Frontiers in Metabolism – Tomorrow’s Clinical Science Today!” The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment, and services.
2024 EXHIBITORS
2022 Exhibitors
2021 Exhibitors
2020 Exhibitors
AstraZeneca
Esperion
Amarin
Abbott
Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
Novartis
Novo Nordisk
19th World Congress Insulin Resistance, DM & CVD
5th Heart in Diabetes
American Society for Preventive Cardiology (ASPC)
2019 Exhibitors
Abbott
Amarin
Amgen
AstraZeneca
Boehringer Ingelheim / Lilly USA
Corcept Therapeutics
EMK Medical Services
Janssen
Lexicon
Lilly
Mediknox
Novo Nordisk
Pharmatech
Salix
Sanofi
VeroScience